We’re a global biopharmaceutical company committed to building patient and doctor confidence in our medicines with an ethical, evidence-based approach, applying world-class science and conducting clinical trials.
Our focus is on specific, targeted conditions, and through this we are reimagining healthcare for millions of people who are underserved by current treatments.
Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are available in Australia and the USA.
Accessing cannabinoid-based medicines in Australia
Medicinal cannabis is available like any other prescription medicines, on written authorisation from a registered medical professional.
Any medical practitioner can prescribe medicinal cannabis for a patient, if the doctor makes an evidence-based judgement that medical cannabis is the appropriate treatment. This assessment is based on the patient’s symptoms, family history and any other previous treatments that have been tried
Like any other prescription, Zelira’s medicines can be dispensed by any pharmacy Australia-wide, with delivery to most Australian locations within 24 hours